Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02758132 |
Title | Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases |
Recruitment | Terminated |
Gender | male |
Phase | Phase I |
Variant Requirements | No |
Sponsors | University of Hawaii |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |